An interventional study of Mobilyze! in Depression, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2017-03-24.
Sponsored by Northwestern University · Not applicable, Interventional, and Other
Investigators are evaluating the use of phone sensor data to estimate behavior, depression and anxiety.
Investigators are evaluating the use of phone sensor data to estimate behavior, depression and anxiety. Participants will include people who are high on depression, high on anxiety, hight on both depression and anxiety, and health controls. Particpants will load software on their phones that collects phone sensor data, and obtains self report on sleep, mood, and social contacts. Data will be collected for at least 6 weeks.
8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 2,010 is above the median of 84 across 6,720 interventional studies indexed under Depression.
Browse Depression studies →Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.
Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: Mobilyze!
Mobilyze! delivers behavioral intervention for depression via a mobile phone, interactive website, and e-mail.
Depression, as assessed the Patient Health Questionnaire-9
Time frame: Baseline, Weeks 2-6
Positive Affect (PANAS - Positive Affect Scale)
Time frame: Baseline, Weeks 2-6
Anxiety (GAD-7)
Time frame: Baseline, Weeks 2-6
This study is completed, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northwestern University